

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 7.58977533 |
| 2 | L-phenylalanine catabolic process (GO:0006559) | 7.58977533 |
| 3 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 7.24476446 |
| 4 | L-phenylalanine metabolic process (GO:0006558) | 7.24476446 |
| 5 | aromatic amino acid family catabolic process (GO:0009074) | 6.81789209 |
| 6 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 6.40306301 |
| 7 | tryptophan catabolic process (GO:0006569) | 6.13394619 |
| 8 | indole-containing compound catabolic process (GO:0042436) | 6.13394619 |
| 9 | indolalkylamine catabolic process (GO:0046218) | 6.13394619 |
| 10 | kynurenine metabolic process (GO:0070189) | 6.02784389 |
| 11 | bile acid biosynthetic process (GO:0006699) | 5.96599090 |
| 12 | regulation of plasminogen activation (GO:0010755) | 5.84909962 |
| 13 | intestinal cholesterol absorption (GO:0030299) | 5.82367632 |
| 14 | glyoxylate metabolic process (GO:0046487) | 5.82082040 |
| 15 | tryptophan metabolic process (GO:0006568) | 5.77944532 |
| 16 | negative regulation of fibrinolysis (GO:0051918) | 5.77899797 |
| 17 | urea metabolic process (GO:0019627) | 5.67879628 |
| 18 | urea cycle (GO:0000050) | 5.67879628 |
| 19 | high-density lipoprotein particle remodeling (GO:0034375) | 5.66861226 |
| 20 | regulation of fibrinolysis (GO:0051917) | 5.56585491 |
| 21 | alpha-linolenic acid metabolic process (GO:0036109) | 5.56380589 |
| 22 | protein carboxylation (GO:0018214) | 5.45701981 |
| 23 | peptidyl-glutamic acid carboxylation (GO:0017187) | 5.45701981 |
| 24 | regulation of protein activation cascade (GO:2000257) | 5.43650168 |
| 25 | complement activation, alternative pathway (GO:0006957) | 5.43193616 |
| 26 | sulfur amino acid catabolic process (GO:0000098) | 5.35451863 |
| 27 | cysteine metabolic process (GO:0006534) | 5.34428659 |
| 28 | exogenous drug catabolic process (GO:0042738) | 5.24549078 |
| 29 | nitrogen cycle metabolic process (GO:0071941) | 5.21898385 |
| 30 | serine family amino acid catabolic process (GO:0009071) | 5.10046062 |
| 31 | bile acid metabolic process (GO:0008206) | 5.09951316 |
| 32 | regulation of complement activation (GO:0030449) | 5.07279967 |
| 33 | epoxygenase P450 pathway (GO:0019373) | 5.03543752 |
| 34 | regulation of apoptotic cell clearance (GO:2000425) | 4.99347653 |
| 35 | reverse cholesterol transport (GO:0043691) | 4.99052753 |
| 36 | aromatic amino acid family metabolic process (GO:0009072) | 4.95001275 |
| 37 | protein-lipid complex subunit organization (GO:0071825) | 4.93684030 |
| 38 | regulation of cholesterol esterification (GO:0010872) | 4.93244711 |
| 39 | negative regulation of protein activation cascade (GO:2000258) | 4.91065194 |
| 40 | negative regulation of blood coagulation (GO:0030195) | 4.87809773 |
| 41 | negative regulation of hemostasis (GO:1900047) | 4.87809773 |
| 42 | protein-lipid complex remodeling (GO:0034368) | 4.87046616 |
| 43 | macromolecular complex remodeling (GO:0034367) | 4.87046616 |
| 44 | plasma lipoprotein particle remodeling (GO:0034369) | 4.87046616 |
| 45 | regulation of triglyceride catabolic process (GO:0010896) | 4.85072292 |
| 46 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.84104471 |
| 47 | tyrosine metabolic process (GO:0006570) | 4.80489029 |
| 48 | homocysteine metabolic process (GO:0050667) | 4.76160680 |
| 49 | triglyceride homeostasis (GO:0070328) | 4.64797842 |
| 50 | acylglycerol homeostasis (GO:0055090) | 4.64797842 |
| 51 | phospholipid efflux (GO:0033700) | 4.64053860 |
| 52 | alpha-amino acid catabolic process (GO:1901606) | 4.63600904 |
| 53 | positive regulation of blood coagulation (GO:0030194) | 4.63233866 |
| 54 | positive regulation of hemostasis (GO:1900048) | 4.63233866 |
| 55 | amino-acid betaine metabolic process (GO:0006577) | 4.58382281 |
| 56 | negative regulation of sterol transport (GO:0032372) | 4.57282155 |
| 57 | negative regulation of cholesterol transport (GO:0032375) | 4.57282155 |
| 58 | lysine catabolic process (GO:0006554) | 4.56297927 |
| 59 | lysine metabolic process (GO:0006553) | 4.56297927 |
| 60 | plasma lipoprotein particle clearance (GO:0034381) | 4.49302535 |
| 61 | cellular ketone body metabolic process (GO:0046950) | 4.47425346 |
| 62 | negative regulation of coagulation (GO:0050819) | 4.47322310 |
| 63 | glycine metabolic process (GO:0006544) | 4.42944648 |
| 64 | bile acid and bile salt transport (GO:0015721) | 4.41744224 |
| 65 | regulation of humoral immune response (GO:0002920) | 4.37405695 |
| 66 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 4.36212524 |
| 67 | imidazole-containing compound metabolic process (GO:0052803) | 4.35530702 |
| 68 | indolalkylamine metabolic process (GO:0006586) | 4.34975970 |
| 69 | coenzyme catabolic process (GO:0009109) | 4.33724950 |
| 70 | cholesterol efflux (GO:0033344) | 4.32262438 |
| 71 | omega-hydroxylase P450 pathway (GO:0097267) | 4.31121306 |
| 72 | negative regulation of wound healing (GO:0061045) | 4.30014963 |
| 73 | cellular amino acid catabolic process (GO:0009063) | 4.26795738 |
| 74 | cellular biogenic amine catabolic process (GO:0042402) | 4.25965643 |
| 75 | amine catabolic process (GO:0009310) | 4.25965643 |
| 76 | positive regulation of coagulation (GO:0050820) | 4.25475042 |
| 77 | cellular glucuronidation (GO:0052695) | 4.24344179 |
| 78 | glutamate metabolic process (GO:0006536) | 4.24170170 |
| 79 | acute-phase response (GO:0006953) | 4.21156349 |
| 80 | serine family amino acid metabolic process (GO:0009069) | 4.18327654 |
| 81 | benzene-containing compound metabolic process (GO:0042537) | 4.11510889 |
| 82 | plasma lipoprotein particle assembly (GO:0034377) | 4.09882774 |
| 83 | fibrinolysis (GO:0042730) | 4.09764744 |
| 84 | low-density lipoprotein particle remodeling (GO:0034374) | 4.08542119 |
| 85 | serine family amino acid biosynthetic process (GO:0009070) | 4.06487943 |
| 86 | ethanol oxidation (GO:0006069) | 4.06348149 |
| 87 | dicarboxylic acid biosynthetic process (GO:0043650) | 4.05488249 |
| 88 | cellular modified amino acid catabolic process (GO:0042219) | 4.04497117 |
| 89 | arginine metabolic process (GO:0006525) | 4.01745659 |
| 90 | negative regulation of complement activation (GO:0045916) | 4.01402146 |
| 91 | aldehyde catabolic process (GO:0046185) | 4.00516692 |
| 92 | lipoprotein metabolic process (GO:0042157) | 3.99248034 |
| 93 | blood coagulation, intrinsic pathway (GO:0007597) | 3.96481895 |
| 94 | ethanol metabolic process (GO:0006067) | 3.96140330 |
| 95 | ketone body metabolic process (GO:1902224) | 3.87409948 |
| 96 | drug catabolic process (GO:0042737) | 3.87392526 |
| 97 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.84220077 |
| 98 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.84220077 |
| 99 | sterol transport (GO:0015918) | 3.82428218 |
| 100 | cholesterol transport (GO:0030301) | 3.82428218 |
| 101 | phospholipid homeostasis (GO:0055091) | 3.81286003 |
| 102 | complement activation, classical pathway (GO:0006958) | 3.80670342 |
| 103 | cofactor catabolic process (GO:0051187) | 3.80641663 |
| 104 | very-low-density lipoprotein particle assembly (GO:0034379) | 3.79884614 |
| 105 | protein activation cascade (GO:0072376) | 3.78461794 |
| 106 | cholesterol homeostasis (GO:0042632) | 3.78261848 |
| 107 | complement activation (GO:0006956) | 3.77737847 |
| 108 | positive regulation of lipid catabolic process (GO:0050996) | 3.77397586 |
| 109 | intestinal absorption (GO:0050892) | 3.76811831 |
| 110 | uronic acid metabolic process (GO:0006063) | 3.76299886 |
| 111 | glucuronate metabolic process (GO:0019585) | 3.76299886 |
| 112 | negative regulation of lipase activity (GO:0060192) | 3.74213792 |
| 113 | positive regulation of fatty acid biosynthetic process (GO:0045723) | 3.72935409 |
| 114 | organic acid catabolic process (GO:0016054) | 3.72532534 |
| 115 | carboxylic acid catabolic process (GO:0046395) | 3.72532534 |
| 116 | sterol homeostasis (GO:0055092) | 3.71888892 |
| 117 | plasma lipoprotein particle organization (GO:0071827) | 3.70993933 |
| 118 | cytolysis (GO:0019835) | 3.69481507 |
| 119 | regulation of bile acid biosynthetic process (GO:0070857) | 3.68925098 |
| 120 | protein-lipid complex assembly (GO:0065005) | 3.67640724 |
| 121 | short-chain fatty acid metabolic process (GO:0046459) | 3.64136201 |
| 122 | acetyl-CoA metabolic process (GO:0006084) | 3.62759960 |
| 123 | drug metabolic process (GO:0017144) | 3.61999537 |
| 124 | regulation of cholesterol homeostasis (GO:2000188) | 3.59143810 |
| 125 | proline metabolic process (GO:0006560) | 3.56226330 |
| 126 | opsonization (GO:0008228) | 3.52808938 |
| 127 | NAD biosynthetic process (GO:0009435) | 3.52305882 |
| 128 | positive regulation of extracellular matrix organization (GO:1903055) | 3.49251316 |
| 129 | positive regulation of steroid metabolic process (GO:0045940) | 3.43657263 |
| 130 | negative regulation of lipid transport (GO:0032369) | 3.38534291 |
| 131 | regulation of cholesterol biosynthetic process (GO:0045540) | 3.37347179 |
| 132 | regulation of lipoprotein particle clearance (GO:0010984) | 3.31924335 |
| 133 | peptidyl-glutamic acid modification (GO:0018200) | 3.28977133 |
| 134 | regulation of systemic arterial blood pressure by renin-angiotensin (GO:0003081) | 3.28521323 |
| 135 | diacylglycerol metabolic process (GO:0046339) | 3.28308679 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 8.38025787 |
| 2 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 7.19510549 |
| 3 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 7.07959052 |
| 4 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 6.52289793 |
| 5 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 5.28787207 |
| 6 | * CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 5.06975721 |
| 7 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 4.78042103 |
| 8 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 4.06850761 |
| 9 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 4.02785374 |
| 10 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 2.07299708 |
| 11 | * ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 11.9576021 |
| 12 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.98362963 |
| 13 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.96849256 |
| 14 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.91892788 |
| 15 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.63900481 |
| 16 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.61045606 |
| 17 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.52509370 |
| 18 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 1.51240409 |
| 19 | GATA1_22025678_ChIP-Seq_K562_Human | 1.49588587 |
| 20 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.41342933 |
| 21 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 1.38356091 |
| 22 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.31127616 |
| 23 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.28928845 |
| 24 | * RXRA_24833708_ChIP-Seq_LIVER_Mouse | 1.17326527 |
| 25 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.15851903 |
| 26 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.15663618 |
| 27 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.13141339 |
| 28 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.10283648 |
| 29 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.00742411 |
| 30 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.00279578 |
| 31 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 0.99492498 |
| 32 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.96527538 |
| 33 | AR_21909140_ChIP-Seq_LNCAP_Human | 0.96053567 |
| 34 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 0.95266603 |
| 35 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 0.92970210 |
| 36 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.91934881 |
| 37 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 0.91522666 |
| 38 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 0.88840058 |
| 39 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.88788257 |
| 40 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.85586353 |
| 41 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.84227561 |
| 42 | GATA3_20176728_ChIP-ChIP_TSCs_Mouse | 0.83871017 |
| 43 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.83165240 |
| 44 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.81680807 |
| 45 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 0.81639087 |
| 46 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 0.81579006 |
| 47 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.80663953 |
| 48 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.80351679 |
| 49 | POU5F1_16518401_ChIP-PET_MESCs_Mouse | 0.79318848 |
| 50 | * GATA4_25053715_ChIP-Seq_YYC3_Human | 0.77792435 |
| 51 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.77764740 |
| 52 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.77690772 |
| 53 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.76879561 |
| 54 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 0.75842810 |
| 55 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.74205339 |
| 56 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.73275789 |
| 57 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 0.73201093 |
| 58 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.73058427 |
| 59 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.72589494 |
| 60 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 0.70656326 |
| 61 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.70042554 |
| 62 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.69274180 |
| 63 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 0.68501783 |
| 64 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.68438536 |
| 65 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.68438536 |
| 66 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.68337015 |
| 67 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.66772431 |
| 68 | TP53_16413492_ChIP-PET_HCT116_Human | 0.65262529 |
| 69 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.64369857 |
| 70 | SMAD1_18555785_Chip-Seq_ESCs_Mouse | 0.63654718 |
| 71 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.62038858 |
| 72 | RAC3_21632823_ChIP-Seq_H3396_Human | 0.61668168 |
| 73 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.61359192 |
| 74 | * RARB_24833708_ChIP-Seq_LIVER_Mouse | 0.60512575 |
| 75 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 0.60465314 |
| 76 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.60362522 |
| 77 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.60187727 |
| 78 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.57762064 |
| 79 | SOX2_21211035_ChIP-Seq_LN229_Human | 0.57333558 |
| 80 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.57092044 |
| 81 | NEUROD2_26341353_ChIP-Seq_CORTEX_Mouse | 0.56389051 |
| 82 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.56209937 |
| 83 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 0.55209808 |
| 84 | SOX11_22085726_ChIP-Seq_ESNs_Mouse | 0.55107698 |
| 85 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.54650773 |
| 86 | ESRRB_18555785_Chip-Seq_ESCs_Mouse | 0.53729815 |
| 87 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.53589973 |
| 88 | SOX17_20123909_ChIP-Seq_XEN_Mouse | 0.53523003 |
| 89 | MYC_19915707_ChIP-ChIP_AK7_Human | 0.52433990 |
| 90 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.52378810 |
| 91 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 0.52360043 |
| 92 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.52303918 |
| 93 | TAF15_26573619_Chip-Seq_HEK293_Human | 0.52085121 |
| 94 | AR_20517297_ChIP-Seq_VCAP_Human | 0.52076650 |
| 95 | FOXA1_26743006_Chip-Seq_LNCaP-abl_Human | 0.50941663 |
| 96 | * FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.49962820 |
| 97 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 0.49837797 |
| 98 | ZFX_18555785_Chip-Seq_ESCs_Mouse | 0.49823032 |
| 99 | CBP_21632823_ChIP-Seq_H3396_Human | 0.49650277 |
| 100 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 0.49412151 |
| 101 | RUNX1_27457419_Chip-Seq_LIVER_Mouse | 0.49287782 |
| 102 | * CSB_26484114_Chip-Seq_FIBROBLAST_Human | 0.49169642 |
| 103 | SMC4_20622854_ChIP-Seq_HELA_Human | 0.48765681 |
| 104 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 0.48437232 |
| 105 | * LXR_22292898_ChIP-Seq_THP-1_Human | 0.47867738 |
| 106 | STAT1_17558387_ChIP-Seq_HELA_Human | 0.47641667 |
| 107 | AR_21572438_ChIP-Seq_LNCaP_Human | 0.47531796 |
| 108 | GATA1_19941826_ChIP-Seq_K562_Human | 0.47431329 |
| 109 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.46983151 |
| 110 | P53_21459846_ChIP-Seq_SAOS-2_Human | 0.46555985 |
| 111 | * ESET_19884257_ChIP-Seq_ESCs_Mouse | 0.46362165 |
| 112 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.45529660 |
| 113 | PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 0.45049966 |
| 114 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.44708223 |
| 115 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.43842727 |
| 116 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.43479910 |
| 117 | TAF2_19829295_ChIP-Seq_ESCs_Human | 0.42783595 |
| 118 | GATA2_19941826_ChIP-Seq_K562_Human | 0.42344646 |
| 119 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.41810256 |
| 120 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.41332165 |
| 121 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 0.40991541 |
| 122 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.40765066 |
| 123 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.40576193 |
| 124 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.39958777 |
| 125 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.39764845 |
| 126 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.39632270 |
| 127 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.38142959 |
| 128 | MYC_27129775_Chip-Seq_CORNEA_Mouse | 0.37527736 |
| 129 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 0.37271368 |
| 130 | STAT3_19079543_ChIP-ChIP_MESCs_Mouse | 0.36760434 |
| 131 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 0.36649172 |
| 132 | LUZP1_20508642_ChIP-Seq_ESCs_Mouse | 0.35751427 |
| 133 | SPI1_26923725_Chip-Seq_HPCs_Mouse | 0.34929149 |
| 134 | * PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.34750832 |
| 135 | NCOR_22424771_ChIP-Seq_293T_Human | 0.34417155 |
| 136 | FOXH1_21741376_ChIP-Seq_EPCs_Human | 0.34261193 |
| 137 | ERG_20517297_ChIP-Seq_VCAP_Human | 0.33865715 |
| 138 | CDX2_22108803_ChIP-Seq_LS180_Human | 0.33846769 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 8.29474337 |
| 2 | MP0005360_urolithiasis | 7.60188742 |
| 3 | MP0005085_abnormal_gallbladder_physiolo | 6.45685556 |
| 4 | MP0005365_abnormal_bile_salt | 6.17378591 |
| 5 | MP0008875_abnormal_xenobiotic_pharmacok | 5.10102180 |
| 6 | MP0003806_abnormal_nucleotide_metabolis | 4.30823095 |
| 7 | MP0003252_abnormal_bile_duct | 3.91795473 |
| 8 | MP0010329_abnormal_lipoprotein_level | 3.62210012 |
| 9 | MP0009840_abnormal_foam_cell | 3.30763665 |
| 10 | MP0003122_maternal_imprinting | 3.14987153 |
| 11 | MP0005083_abnormal_biliary_tract | 3.12742379 |
| 12 | MP0003195_calcinosis | 2.84091167 |
| 13 | MP0005332_abnormal_amino_acid | 2.74619699 |
| 14 | MP0001666_abnormal_nutrient_absorption | 2.60187625 |
| 15 | MP0003191_abnormal_cellular_cholesterol | 2.36509494 |
| 16 | MP0000609_abnormal_liver_physiology | 2.17001794 |
| 17 | MP0004019_abnormal_vitamin_homeostasis | 2.12763204 |
| 18 | MP0002118_abnormal_lipid_homeostasis | 2.10739530 |
| 19 | MP0002138_abnormal_hepatobiliary_system | 1.95481729 |
| 20 | MP0003868_abnormal_feces_composition | 1.93755209 |
| 21 | MP0005319_abnormal_enzyme/_coenzyme | 1.82414159 |
| 22 | MP0001764_abnormal_homeostasis | 1.68272820 |
| 23 | MP0009697_abnormal_copulation | 1.65100654 |
| 24 | MP0001915_intracranial_hemorrhage | 1.64577683 |
| 25 | MP0000566_synostosis | 1.62428000 |
| 26 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.57676407 |
| 27 | MP0003123_paternal_imprinting | 1.46013794 |
| 28 | MP0002089_abnormal_postnatal_growth/wei | 1.42633652 |
| 29 | MP0003011_delayed_dark_adaptation | 1.42202841 |
| 30 | MP0005451_abnormal_body_composition | 1.38803284 |
| 31 | MP0003656_abnormal_erythrocyte_physiolo | 1.35715239 |
| 32 | MP0003186_abnormal_redox_activity | 1.26498031 |
| 33 | MP0009643_abnormal_urine_homeostasis | 1.22370480 |
| 34 | MP0003172_abnormal_lysosome_physiology | 1.22324348 |
| 35 | MP0000598_abnormal_liver_morphology | 1.18105231 |
| 36 | MP0005647_abnormal_sex_gland | 1.13558144 |
| 37 | MP0000604_amyloidosis | 1.13112462 |
| 38 | MP0003705_abnormal_hypodermis_morpholog | 1.12826074 |
| 39 | MP0002254_reproductive_system_inflammat | 1.04895894 |
| 40 | MP0009764_decreased_sensitivity_to | 1.04824081 |
| 41 | MP0009763_increased_sensitivity_to | 1.03110835 |
| 42 | MP0010368_abnormal_lymphatic_system | 1.00625718 |
| 43 | MP0005636_abnormal_mineral_homeostasis | 0.93650772 |
| 44 | MP0008469_abnormal_protein_level | 0.89436714 |
| 45 | MP0005408_hypopigmentation | 0.88746933 |
| 46 | MP0005409_darkened_coat_color | 0.86502918 |
| 47 | * MP0009642_abnormal_blood_homeostasis | 0.86279062 |
| 48 | MP0004272_abnormal_basement_membrane | 0.81428335 |
| 49 | MP0006036_abnormal_mitochondrial_physio | 0.81297086 |
| 50 | MP0005084_abnormal_gallbladder_morpholo | 0.79913781 |
| 51 | MP0009765_abnormal_xenobiotic_induced | 0.79419068 |
| 52 | MP0009780_abnormal_chondrocyte_physiolo | 0.78515981 |
| 53 | MP0006054_spinal_hemorrhage | 0.77867806 |
| 54 | MP0002078_abnormal_glucose_homeostasis | 0.77678549 |
| 55 | MP0002876_abnormal_thyroid_physiology | 0.76525863 |
| 56 | MP0003121_genomic_imprinting | 0.73991644 |
| 57 | * MP0005376_homeostasis/metabolism_phenot | 0.73908953 |
| 58 | MP0005220_abnormal_exocrine_pancreas | 0.73579855 |
| 59 | MP0005670_abnormal_white_adipose | 0.73530593 |
| 60 | MP0003690_abnormal_glial_cell | 0.72454564 |
| 61 | MP0003879_abnormal_hair_cell | 0.70982896 |
| 62 | MP0002971_abnormal_brown_adipose | 0.70528192 |
| 63 | MP0001661_extended_life_span | 0.69393089 |
| 64 | MP0004130_abnormal_muscle_cell | 0.68479107 |
| 65 | MP0005334_abnormal_fat_pad | 0.67530739 |
| 66 | MP0005535_abnormal_body_temperature | 0.67095727 |
| 67 | MP0003329_amyloid_beta_deposits | 0.66860539 |
| 68 | MP0005257_abnormal_intraocular_pressure | 0.65591319 |
| 69 | MP0009053_abnormal_anal_canal | 0.65207189 |
| 70 | MP0005266_abnormal_metabolism | 0.64186469 |
| 71 | MP0000639_abnormal_adrenal_gland | 0.63157220 |
| 72 | MP0003183_abnormal_peptide_metabolism | 0.60977760 |
| 73 | MP0003567_abnormal_fetal_cardiomyocyte | 0.59614458 |
| 74 | MP0002282_abnormal_trachea_morphology | 0.57985124 |
| 75 | MP0001756_abnormal_urination | 0.57219657 |
| 76 | MP0006035_abnormal_mitochondrial_morpho | 0.55900325 |
| 77 | MP0005448_abnormal_energy_balance | 0.55249549 |
| 78 | MP0003950_abnormal_plasma_membrane | 0.54626923 |
| 79 | MP0005377_hearing/vestibular/ear_phenot | 0.50708832 |
| 80 | MP0003878_abnormal_ear_physiology | 0.50708832 |
| 81 | MP0004264_abnormal_extraembryonic_tissu | 0.49875045 |
| 82 | MP0003632_abnormal_nervous_system | 0.49775742 |
| 83 | MP0000920_abnormal_myelination | 0.49263607 |
| 84 | MP0002909_abnormal_adrenal_gland | 0.49252404 |
| 85 | MP0002822_catalepsy | 0.49035028 |
| 86 | MP0005395_other_phenotype | 0.48871912 |
| 87 | MP0002933_joint_inflammation | 0.47798514 |
| 88 | MP0003718_maternal_effect | 0.46997910 |
| 89 | MP0002928_abnormal_bile_duct | 0.45637074 |
| 90 | MP0005023_abnormal_wound_healing | 0.45618541 |
| 91 | MP0008874_decreased_physiological_sensi | 0.45613092 |
| 92 | MP0003638_abnormal_response/metabolism_ | 0.45039491 |
| 93 | MP0008873_increased_physiological_sensi | 0.44562857 |
| 94 | MP0002136_abnormal_kidney_physiology | 0.43774279 |
| 95 | MP0004782_abnormal_surfactant_physiolog | 0.42830396 |
| 96 | MP0001270_distended_abdomen | 0.42403275 |
| 97 | MP0003075_altered_response_to | 0.42195835 |
| 98 | MP0001324_abnormal_eye_pigmentation | 0.42144040 |
| 99 | MP0003436_decreased_susceptibility_to | 0.41924563 |
| 100 | MP0002837_dystrophic_cardiac_calcinosis | 0.41669777 |
| 101 | MP0003724_increased_susceptibility_to | 0.41158170 |
| 102 | MP0003953_abnormal_hormone_level | 0.40161284 |
| 103 | MP0004381_abnormal_hair_follicle | 0.40125495 |
| 104 | MP0003943_abnormal_hepatobiliary_system | 0.40018996 |
| 105 | * MP0005464_abnormal_platelet_physiology | 0.39360554 |
| 106 | MP0005410_abnormal_fertilization | 0.39040018 |
| 107 | MP0000003_abnormal_adipose_tissue | 0.38743763 |
| 108 | MP0005248_abnormal_Harderian_gland | 0.38700823 |
| 109 | MP0008872_abnormal_physiological_respon | 0.38545401 |
| 110 | MP0003566_abnormal_cell_adhesion | 0.38323177 |
| 111 | MP0005166_decreased_susceptibility_to | 0.38116577 |
| 112 | MP0002938_white_spotting | 0.37961446 |
| 113 | MP0003115_abnormal_respiratory_system | 0.37061884 |
| 114 | MP0009672_abnormal_birth_weight | 0.36898751 |
| 115 | MP0003941_abnormal_skin_development | 0.36384132 |
| 116 | MP0000579_abnormal_nail_morphology | 0.34822570 |
| 117 | MP0005666_abnormal_adipose_tissue | 0.34156493 |
| 118 | MP0003315_abnormal_perineum_morphology | 0.33630132 |
| 119 | MP0002796_impaired_skin_barrier | 0.33049768 |
| 120 | MP0006082_CNS_inflammation | 0.32079232 |
| 121 | MP0001243_abnormal_dermal_layer | 0.31797809 |
| 122 | MP0009115_abnormal_fat_cell | 0.31528256 |
| 123 | MP0003631_nervous_system_phenotype | 0.30961178 |
| 124 | MP0009384_cardiac_valve_regurgitation | 0.30942654 |
| 125 | MP0000230_abnormal_systemic_arterial | 0.30690197 |
| 126 | MP0002128_abnormal_blood_circulation | 0.30660265 |
| 127 | MP0005379_endocrine/exocrine_gland_phen | 0.30273841 |
| 128 | MP0002168_other_aberrant_phenotype | 0.29622430 |
| 129 | MP0005076_abnormal_cell_differentiation | 0.29548902 |
| 130 | MP0002970_abnormal_white_adipose | 0.28698260 |
| 131 | MP0001853_heart_inflammation | 0.28491891 |
| 132 | MP0001845_abnormal_inflammatory_respons | 0.27843351 |
| 133 | MP0001881_abnormal_mammary_gland | 0.26930304 |
| 134 | * MP0000249_abnormal_blood_vessel | 0.25879464 |
| 135 | MP0002132_abnormal_respiratory_system | 0.25091909 |
| 136 | MP0002090_abnormal_vision | 0.24460601 |
| 137 | MP0005058_abnormal_lysosome_morphology | 0.23185612 |
| 138 | MP0005167_abnormal_blood-brain_barrier | 0.22809932 |
| 139 | MP0002060_abnormal_skin_morphology | 0.22668192 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 7.41136656 |
| 2 | Intrahepatic cholestasis (HP:0001406) | 7.38640981 |
| 3 | * Deep venous thrombosis (HP:0002625) | 7.00243602 |
| 4 | Prolonged partial thromboplastin time (HP:0003645) | 6.73087851 |
| 5 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 6.62613884 |
| 6 | Hypobetalipoproteinemia (HP:0003563) | 6.46424165 |
| 7 | Xanthomatosis (HP:0000991) | 6.32207513 |
| 8 | Hyperlipoproteinemia (HP:0010980) | 5.58611343 |
| 9 | Complement deficiency (HP:0004431) | 5.49655684 |
| 10 | Joint hemorrhage (HP:0005261) | 4.94622277 |
| 11 | Hypolipoproteinemia (HP:0010981) | 4.86893181 |
| 12 | Hyperammonemia (HP:0001987) | 4.60359202 |
| 13 | Abnormality of the common coagulation pathway (HP:0010990) | 4.57519358 |
| 14 | Epidermoid cyst (HP:0200040) | 4.51602851 |
| 15 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 4.45703306 |
| 16 | Hyperglycinemia (HP:0002154) | 4.42000501 |
| 17 | Abnormality of methionine metabolism (HP:0010901) | 4.27098576 |
| 18 | Hypoalphalipoproteinemia (HP:0003233) | 4.25537224 |
| 19 | Ketosis (HP:0001946) | 4.23001266 |
| 20 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 4.22790976 |
| 21 | Fat malabsorption (HP:0002630) | 4.17113026 |
| 22 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 4.11098214 |
| 23 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 4.09877122 |
| 24 | Abnormality of complement system (HP:0005339) | 4.00518613 |
| 25 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.90324598 |
| 26 | Abnormality of glycine metabolism (HP:0010895) | 3.90324598 |
| 27 | Hyperglycinuria (HP:0003108) | 3.87443499 |
| 28 | Hypoglycemic coma (HP:0001325) | 3.85723248 |
| 29 | Abnormality of the intrinsic pathway (HP:0010989) | 3.85061706 |
| 30 | Abnormality of pyrimidine metabolism (HP:0004353) | 3.79658466 |
| 31 | Conjugated hyperbilirubinemia (HP:0002908) | 3.78037340 |
| 32 | Hypercholesterolemia (HP:0003124) | 3.65180602 |
| 33 | Hyperbilirubinemia (HP:0002904) | 3.39941265 |
| 34 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 3.32746895 |
| 35 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.28919498 |
| 36 | Steatorrhea (HP:0002570) | 3.13125467 |
| 37 | Purpura (HP:0000979) | 3.11415185 |
| 38 | Delayed CNS myelination (HP:0002188) | 3.11206649 |
| 39 | Hypochromic microcytic anemia (HP:0004840) | 3.11119670 |
| 40 | Spontaneous abortion (HP:0005268) | 3.10777192 |
| 41 | Abnormality of serum amino acid levels (HP:0003112) | 3.06367707 |
| 42 | Hepatocellular carcinoma (HP:0001402) | 3.02620915 |
| 43 | Abnormality of nucleobase metabolism (HP:0010932) | 3.01194863 |
| 44 | Ketoacidosis (HP:0001993) | 2.97081409 |
| 45 | Myocardial infarction (HP:0001658) | 2.93279091 |
| 46 | Skin nodule (HP:0200036) | 2.78263575 |
| 47 | Systemic lupus erythematosus (HP:0002725) | 2.77401038 |
| 48 | Metabolic acidosis (HP:0001942) | 2.74929800 |
| 49 | Osteomalacia (HP:0002749) | 2.73325777 |
| 50 | Acanthocytosis (HP:0001927) | 2.72097482 |
| 51 | Abnormality of purine metabolism (HP:0004352) | 2.61963062 |
| 52 | Abnormality of carpal bone ossification (HP:0006257) | 2.58647893 |
| 53 | Arthropathy (HP:0003040) | 2.57973057 |
| 54 | Lethargy (HP:0001254) | 2.57950390 |
| 55 | Vascular calcification (HP:0004934) | 2.57193585 |
| 56 | Dicarboxylic aciduria (HP:0003215) | 2.54980131 |
| 57 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.54980131 |
| 58 | Glomerulonephritis (HP:0000099) | 2.54305562 |
| 59 | Abnormal gallbladder morphology (HP:0012437) | 2.52475500 |
| 60 | Hypoglycemic seizures (HP:0002173) | 2.49317331 |
| 61 | Abnormal tarsal ossification (HP:0008369) | 2.48572429 |
| 62 | Cholelithiasis (HP:0001081) | 2.45966753 |
| 63 | Spastic diplegia (HP:0001264) | 2.43654707 |
| 64 | Cerebral edema (HP:0002181) | 2.42416419 |
| 65 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.42276296 |
| 66 | Mitral stenosis (HP:0001718) | 2.41361091 |
| 67 | Gout (HP:0001997) | 2.37590898 |
| 68 | Cholecystitis (HP:0001082) | 2.36982340 |
| 69 | Abnormal gallbladder physiology (HP:0012438) | 2.36982340 |
| 70 | Amyloidosis (HP:0011034) | 2.35517130 |
| 71 | Irritability (HP:0000737) | 2.34366909 |
| 72 | Neonatal onset (HP:0003623) | 2.32861399 |
| 73 | Gingival bleeding (HP:0000225) | 2.29175191 |
| 74 | Cardiovascular calcification (HP:0011915) | 2.27880140 |
| 75 | Broad alveolar ridges (HP:0000187) | 2.27040173 |
| 76 | Esophageal varix (HP:0002040) | 2.20971251 |
| 77 | Menorrhagia (HP:0000132) | 2.20225488 |
| 78 | Malnutrition (HP:0004395) | 2.19951791 |
| 79 | Pancreatic islet-cell hyperplasia (HP:0004510) | 2.15282724 |
| 80 | Pancreatitis (HP:0001733) | 2.14072849 |
| 81 | Poikilocytosis (HP:0004447) | 2.13812696 |
| 82 | Thrombophlebitis (HP:0004418) | 2.12362678 |
| 83 | Sensorimotor neuropathy (HP:0007141) | 2.11710219 |
| 84 | Pulmonary embolism (HP:0002204) | 2.11640940 |
| 85 | Enlarged kidneys (HP:0000105) | 2.10663452 |
| 86 | Abnormality of the Achilles tendon (HP:0005109) | 2.09446539 |
| 87 | Flat acetabular roof (HP:0003180) | 2.09408320 |
| 88 | Brushfield spots (HP:0001088) | 2.08684936 |
| 89 | Late onset (HP:0003584) | 2.05795249 |
| 90 | Small epiphyses (HP:0010585) | 2.05477700 |
| 91 | Vomiting (HP:0002013) | 2.04682563 |
| 92 | Abnormality of the gallbladder (HP:0005264) | 2.04082971 |
| 93 | Increased serum pyruvate (HP:0003542) | 2.03544828 |
| 94 | Opisthotonus (HP:0002179) | 2.02548427 |
| 95 | Hyperinsulinemic hypoglycemia (HP:0000825) | 2.01966320 |
| 96 | Hemorrhage of the eye (HP:0011885) | 2.00839533 |
| 97 | Generalized aminoaciduria (HP:0002909) | 1.99178862 |
| 98 | Bifid scrotum (HP:0000048) | 1.95310330 |
| 99 | Rickets (HP:0002748) | 1.95109704 |
| 100 | Abnormality of the lumbar spine (HP:0100712) | 1.93148212 |
| 101 | Abnormality of iron homeostasis (HP:0011031) | 1.91706456 |
| 102 | Abnormal hand bone ossification (HP:0010660) | 1.89915103 |
| 103 | Hypophosphatemic rickets (HP:0004912) | 1.89639241 |
| 104 | Asymmetry of the thorax (HP:0001555) | 1.89594379 |
| 105 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.89067561 |
| 106 | Facial shape deformation (HP:0011334) | 1.87716806 |
| 107 | Potter facies (HP:0002009) | 1.87716806 |
| 108 | Abnormality of the nasal septum (HP:0000419) | 1.86462780 |
| 109 | Abnormal ossification of hand bones (HP:0005921) | 1.86141435 |
| 110 | Epistaxis (HP:0000421) | 1.85345059 |
| 111 | Vaginal fistula (HP:0004320) | 1.85293992 |
| 112 | Abnormal cartilage morphology (HP:0002763) | 1.84717916 |
| 113 | Hepatoblastoma (HP:0002884) | 1.83548618 |
| 114 | Abnormality of glycolysis (HP:0004366) | 1.82482553 |
| 115 | Renal cortical cysts (HP:0000803) | 1.82457260 |
| 116 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.82067683 |
| 117 | Abnormality of proline metabolism (HP:0010907) | 1.81379771 |
| 118 | Hydroxyprolinuria (HP:0003080) | 1.81379771 |
| 119 | Elevated hepatic transaminases (HP:0002910) | 1.80574050 |
| 120 | Nephritis (HP:0000123) | 1.79354579 |
| 121 | Alkalosis (HP:0001948) | 1.78614814 |
| 122 | Status epilepticus (HP:0002133) | 1.77356102 |
| 123 | Broad palm (HP:0001169) | 1.77178746 |
| 124 | Abnormality of vitamin metabolism (HP:0100508) | 1.74582556 |
| 125 | Reticulocytosis (HP:0001923) | 1.74239649 |
| 126 | Reduced antithrombin III activity (HP:0001976) | 1.71213363 |
| 127 | Joint swelling (HP:0001386) | 1.70877423 |
| 128 | Peritonitis (HP:0002586) | 1.70133820 |
| 129 | Abnormal delivery (HP:0001787) | 1.65609896 |
| 130 | Pigmentary retinal degeneration (HP:0001146) | 1.64826076 |
| 131 | Submucous cleft hard palate (HP:0000176) | 1.63325397 |
| 132 | Hyperphosphaturia (HP:0003109) | 1.59906962 |
| 133 | Proximal tubulopathy (HP:0000114) | 1.57628405 |
| 134 | Fair hair (HP:0002286) | 1.56881520 |
| 135 | Glycosuria (HP:0003076) | 1.54827540 |
| 136 | Abnormality of urine glucose concentration (HP:0011016) | 1.54827540 |
| 137 | Prenatal maternal abnormality (HP:0002686) | 1.53716211 |
| 138 | Gangrene (HP:0100758) | 1.53377836 |
| 139 | Retinal atrophy (HP:0001105) | 1.52417781 |
| 140 | Abnormal foot bone ossification (HP:0010675) | 1.52098791 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BCKDK | 7.22887632 |
| 2 | FGFR4 | 4.63519059 |
| 3 | SIK1 | 4.62806210 |
| 4 | ERN1 | 4.27969638 |
| 5 | WNK4 | 3.29250755 |
| 6 | TAOK3 | 3.14360850 |
| 7 | CDK12 | 3.07347754 |
| 8 | INSRR | 3.03429191 |
| 9 | ERBB4 | 2.89335522 |
| 10 | MAP2K4 | 2.36623486 |
| 11 | TYRO3 | 2.27435855 |
| 12 | PKN2 | 2.19890284 |
| 13 | MST1R | 2.15805394 |
| 14 | FGFR1 | 2.12273624 |
| 15 | PDGFRA | 1.98068010 |
| 16 | MAPK11 | 1.91981210 |
| 17 | FLT3 | 1.90708814 |
| 18 | PIK3CG | 1.86677858 |
| 19 | AKT3 | 1.74059515 |
| 20 | TYK2 | 1.73707811 |
| 21 | TRIB3 | 1.72855181 |
| 22 | WNK1 | 1.69325384 |
| 23 | DAPK2 | 1.63193791 |
| 24 | LATS1 | 1.59454199 |
| 25 | EIF2AK1 | 1.49334022 |
| 26 | ABL2 | 1.47502316 |
| 27 | PTK6 | 1.46431313 |
| 28 | SIK2 | 1.44069145 |
| 29 | FGFR2 | 1.43740780 |
| 30 | NEK9 | 1.37727166 |
| 31 | FRK | 1.36076251 |
| 32 | KDR | 1.30485382 |
| 33 | MAP3K2 | 1.26935226 |
| 34 | JAK2 | 1.23985751 |
| 35 | MAP3K7 | 1.19444298 |
| 36 | PINK1 | 1.15124274 |
| 37 | PRKAA2 | 1.11680891 |
| 38 | GRK6 | 1.07316609 |
| 39 | EEF2K | 1.06746020 |
| 40 | MAP2K3 | 1.06711487 |
| 41 | ERBB2 | 1.04425000 |
| 42 | JAK1 | 1.02406856 |
| 43 | TBK1 | 1.00793373 |
| 44 | DDR2 | 1.00378906 |
| 45 | MAP3K14 | 1.00069432 |
| 46 | MAPK4 | 0.98266866 |
| 47 | MAP3K10 | 0.95870237 |
| 48 | NTRK3 | 0.94185020 |
| 49 | MET | 0.94129031 |
| 50 | PRKCZ | 0.92957340 |
| 51 | EPHB1 | 0.91498313 |
| 52 | MAPKAPK3 | 0.86573585 |
| 53 | FGR | 0.85522246 |
| 54 | MAPK12 | 0.83974386 |
| 55 | MAP3K3 | 0.82397108 |
| 56 | EPHA3 | 0.82350899 |
| 57 | CDK7 | 0.81816233 |
| 58 | STK38L | 0.79859060 |
| 59 | SGK1 | 0.79630215 |
| 60 | CDK6 | 0.79380647 |
| 61 | MAPK15 | 0.78478522 |
| 62 | TIE1 | 0.77626012 |
| 63 | PRKACG | 0.77615323 |
| 64 | CSNK1E | 0.77340569 |
| 65 | MAP3K11 | 0.75759484 |
| 66 | RPS6KB1 | 0.74369539 |
| 67 | CAMK2G | 0.74262194 |
| 68 | BCR | 0.70822081 |
| 69 | CAMK1D | 0.69902582 |
| 70 | CSK | 0.69189418 |
| 71 | GSK3A | 0.68836675 |
| 72 | DYRK1B | 0.67509570 |
| 73 | PRKAA1 | 0.65237903 |
| 74 | CDC42BPA | 0.63223503 |
| 75 | SGK3 | 0.63073784 |
| 76 | MAP2K6 | 0.61808389 |
| 77 | RIPK1 | 0.58878625 |
| 78 | MAPK7 | 0.58469575 |
| 79 | TGFBR2 | 0.57660832 |
| 80 | BRD4 | 0.56714389 |
| 81 | CSF1R | 0.56599438 |
| 82 | FGFR3 | 0.55794077 |
| 83 | PDK2 | 0.55762767 |
| 84 | KSR2 | 0.55734008 |
| 85 | PTK2 | 0.55681052 |
| 86 | PRKCQ | 0.55516260 |
| 87 | IRAK3 | 0.55310495 |
| 88 | CSNK1D | 0.53827045 |
| 89 | PDPK1 | 0.52266924 |
| 90 | IKBKE | 0.51878392 |
| 91 | NEK1 | 0.51776130 |
| 92 | EPHA4 | 0.51348245 |
| 93 | BRSK1 | 0.51150932 |
| 94 | CSNK1G1 | 0.50892411 |
| 95 | BRSK2 | 0.49051664 |
| 96 | PKN1 | 0.48608136 |
| 97 | NEK2 | 0.47924933 |
| 98 | SGK2 | 0.46562470 |
| 99 | GRK1 | 0.46549846 |
| 100 | RET | 0.45476617 |
| 101 | PBK | 0.45213558 |
| 102 | IGF1R | 0.44382037 |
| 103 | MATK | 0.42654145 |
| 104 | SRC | 0.42648301 |
| 105 | ICK | 0.42296754 |
| 106 | PRKCG | 0.42173269 |
| 107 | PRKG1 | 0.42100663 |
| 108 | MAP2K1 | 0.41878524 |
| 109 | EPHA2 | 0.41598896 |
| 110 | MAP3K5 | 0.41595459 |
| 111 | NLK | 0.41582571 |
| 112 | TAOK2 | 0.41308823 |
| 113 | CSNK2A2 | 0.40857401 |
| 114 | CDK4 | 0.39933729 |
| 115 | SGK223 | 0.39054894 |
| 116 | SGK494 | 0.39054894 |
| 117 | MAP3K13 | 0.38844289 |
| 118 | RPS6KA3 | 0.38647293 |
| 119 | CSNK2A1 | 0.34755283 |
| 120 | MTOR | 0.34398789 |
| 121 | EGFR | 0.33953019 |
| 122 | MAP3K6 | 0.33834401 |
| 123 | PDK1 | 0.33316173 |
| 124 | STK39 | 0.32119204 |
| 125 | CSNK1G2 | 0.31625077 |
| 126 | CDK8 | 0.31304977 |
| 127 | CAMK4 | 0.31172927 |
| 128 | SMG1 | 0.30524183 |
| 129 | PDGFRB | 0.29653447 |
| 130 | PRKCB | 0.28801565 |
| 131 | CDK9 | 0.28537425 |
| 132 | CSNK1G3 | 0.28271885 |
| 133 | NTRK2 | 0.28135476 |
| 134 | MAP3K1 | 0.27163905 |
| 135 | PRKCA | 0.26792696 |
| 136 | MELK | 0.26524721 |
| 137 | MUSK | 0.25192711 |
| 138 | PAK3 | 0.24342453 |
| 139 | CAMK1G | 0.23276581 |
| 140 | IRAK1 | 0.21849895 |
| 141 | PIK3CA | 0.21614763 |
| 142 | IRAK2 | 0.21388488 |
| 143 | ABL1 | 0.20927355 |
| 144 | LATS2 | 0.20301543 |
| 145 | BMX | 0.19561790 |
| 146 | PRKACB | 0.19531506 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 4.53141275 |
| 2 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.70796641 |
| 3 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.38243280 |
| 4 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.33694743 |
| 5 | Arginine biosynthesis_Homo sapiens_hsa00220 | 3.07893667 |
| 6 | * Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.77358085 |
| 7 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.68256400 |
| 8 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.67705621 |
| 9 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.64358944 |
| 10 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.56849434 |
| 11 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.46634011 |
| 12 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.37868053 |
| 13 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.21951513 |
| 14 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.14976427 |
| 15 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 2.14452087 |
| 16 | Peroxisome_Homo sapiens_hsa04146 | 2.05065898 |
| 17 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.95385493 |
| 18 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.93090250 |
| 19 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.93047979 |
| 20 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.92250766 |
| 21 | Histidine metabolism_Homo sapiens_hsa00340 | 1.91114176 |
| 22 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.84031392 |
| 23 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.79992701 |
| 24 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.79816847 |
| 25 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.75405627 |
| 26 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.74751236 |
| 27 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.73264872 |
| 28 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.69935040 |
| 29 | Retinol metabolism_Homo sapiens_hsa00830 | 1.69603211 |
| 30 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.63887198 |
| 31 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.63265799 |
| 32 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.57728731 |
| 33 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.55338063 |
| 34 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.49652034 |
| 35 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.49493232 |
| 36 | Bile secretion_Homo sapiens_hsa04976 | 1.48582071 |
| 37 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.44082602 |
| 38 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.37353379 |
| 39 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.35848868 |
| 40 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.34964153 |
| 41 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.30709884 |
| 42 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.26814179 |
| 43 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.24011960 |
| 44 | ABC transporters_Homo sapiens_hsa02010 | 1.20907817 |
| 45 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.19855819 |
| 46 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.19540981 |
| 47 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.18346348 |
| 48 | Carbon metabolism_Homo sapiens_hsa01200 | 1.11531570 |
| 49 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.03039202 |
| 50 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.02675454 |
| 51 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.01113046 |
| 52 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.00069953 |
| 53 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.97419024 |
| 54 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.96382312 |
| 55 | Sulfur relay system_Homo sapiens_hsa04122 | 0.92948016 |
| 56 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.87233584 |
| 57 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.85894359 |
| 58 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.82781417 |
| 59 | Lysine degradation_Homo sapiens_hsa00310 | 0.79892374 |
| 60 | Other glycan degradation_Homo sapiens_hsa00511 | 0.79087951 |
| 61 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.76368492 |
| 62 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.68530113 |
| 63 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.66436646 |
| 64 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.65301161 |
| 65 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.56178643 |
| 66 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.53293135 |
| 67 | Metabolic pathways_Homo sapiens_hsa01100 | 0.45586807 |
| 68 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.45101998 |
| 69 | Pertussis_Homo sapiens_hsa05133 | 0.44048547 |
| 70 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.38613088 |
| 71 | Prion diseases_Homo sapiens_hsa05020 | 0.38275401 |
| 72 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.34147970 |
| 73 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.26059223 |
| 74 | Galactose metabolism_Homo sapiens_hsa00052 | 0.24460492 |
| 75 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.23657059 |
| 76 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.23233361 |
| 77 | Insulin resistance_Homo sapiens_hsa04931 | 0.22131066 |
| 78 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.21079256 |
| 79 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.21060810 |
| 80 | Mineral absorption_Homo sapiens_hsa04978 | 0.18245118 |
| 81 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.15680965 |
| 82 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.08665295 |
| 83 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.08143631 |
| 84 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.01016400 |
| 85 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | -0.2477835 |
| 86 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | -0.2398866 |
| 87 | Amoebiasis_Homo sapiens_hsa05146 | -0.2349438 |
| 88 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | -0.2249380 |
| 89 | Ether lipid metabolism_Homo sapiens_hsa00565 | -0.2211707 |
| 90 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | -0.1951462 |
| 91 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | -0.1890628 |
| 92 | Renin-angiotensin system_Homo sapiens_hsa04614 | -0.1881067 |
| 93 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | -0.1877273 |
| 94 | Hepatitis C_Homo sapiens_hsa05160 | -0.1802731 |
| 95 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | -0.1644541 |
| 96 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | -0.1636117 |
| 97 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | -0.1626574 |
| 98 | Regulation of autophagy_Homo sapiens_hsa04140 | -0.1399198 |
| 99 | Lysosome_Homo sapiens_hsa04142 | -0.1309545 |
| 100 | African trypanosomiasis_Homo sapiens_hsa05143 | -0.1308777 |
| 101 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | -0.1306760 |
| 102 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | -0.1227297 |
| 103 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | -0.1101088 |
| 104 | Insulin signaling pathway_Homo sapiens_hsa04910 | -0.1093129 |
| 105 | Circadian rhythm_Homo sapiens_hsa04710 | -0.1074103 |
| 106 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | -0.0832637 |
| 107 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | -0.0787938 |
| 108 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | -0.0661135 |
| 109 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | -0.0474168 |
| 110 | ECM-receptor interaction_Homo sapiens_hsa04512 | -0.0301504 |

